Evidence map›Paper›PMID 34037528›Full record

Observational studyJMIR mHealth and uHealth2021

Comparative Analysis of Single and Combined Antipyretics Using Patient-Generated Health Data: Retrospective Observational Study.

Yu Rang Park, Hyery Kim, Ji Ae Park, Sang Hyun Ahn, Seyun Chang, Jae Won Shin, Myeongchan Kim, Jae-Ho Lee

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in JMIR mHealth and uHealth, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yu Rang Park *Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-4210-2094
Hyery Kim *Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Republic of Korea.ORCID 0000-0003-2852-6832
Ji Ae ParkDepartment of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-8717-1587
Sang Hyun AhnKorea Human Resource Development Institute for Health & Welfare, Cheongju, Republic of Korea.ORCID 0000-0003-3593-2855
Seyun ChangMobile Doctor Co, Ltd, Seoul, Republic of Korea.ORCID 0000-0002-0397-587X
Jae Won ShinMobile Doctor Co, Ltd, Seoul, Republic of Korea.ORCID 0000-0001-5272-3081
Myeongchan KimMobile Doctor Co, Ltd, Seoul, Republic of Korea.ORCID 0000-0003-3940-9850
Jae-Ho LeeDepartment of Information Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.ORCID 0000-0003-2619-1231
Yonsei University · KRAsan Medical Center · KRKorea Human Resource Development Institute for Health and Welfare · KRUlsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFever is one of the most common symptoms in children and is the physiological response of the human immune system to external pathogens. However, effectiveness studies of single and combined antipyretic therapy are relatively few due to lack of data. In this study, we used large-scale patient-generated health data from mobile apps to compare antipyretic affects between single and combination antipyretics.

objectiveWe aimed to establish combination patterns of antipyretics and compare antipyretic affects between single and combination antipyretics using large-scale patient-generated health data from mobile apps.

methodsThis study was conducted using medical records of feverish children from July 2015 to June 2017 using the Fever Coach mobile app. In total, 3,584,748 temperature records and 1,076,002 antipyretic records of 104,337 children were analyzed. Antipyretic efficacy was measured by the mean difference in the area under the temperature change curve from baseline for 6 hours, 8 hours, 10 hours, and 12 hours after antipyretic administration in children with a body temperature of ≥38.0 ℃ between single and combination groups.

resultsThe single antipyretic and combination groups comprised 152,017 and 54,842 cases, respectively. Acetaminophen was the most commonly used single agent (60,929/152,017, 40.08%), and acetaminophen plus dexibuprofen was the most common combination (28,065/54,842, 51.17%). We observed inappropriate use, including triple combination (1205/206,859, 0.58%) and use under 38 ℃ (11,361/206,859, 5.50%). Combination antipyretic use increased with temperature; 23.82% (33,379/140,160) of cases were given a combination treatment when 38 ℃ ≤ temperature < 39 ℃, while 41.40% (1517/3664) were given a combination treatment when 40 ℃ ≤ temperature. The absolute value of the area under the curve at each hour was significantly higher in the single group than in the combination group; this trend was consistently observed, regardless of the type of antipyretics. In particular, the delta fever during the first 6 hours between the two groups showed the highest difference. The combination showed the lowest delta fever among all cases.

conclusionsAntipyretics combination patterns were analyzed using large-scale data. Approximately 75% of febrile cases used single antipyretics, mostly acetaminophen, but combination usage became more frequent as temperature increased. However, combination antipyretics did not show definite advantages over single antipyretics in defervescence, regardless of the combination. Single antipyretics are effective in reducing fever and relieving discomfort in febrile children.

Indexed as

AntipyreticsMobile ApplicationsAcetaminophenChildFeverHumansRetrospective StudiesAcetaminophenAntipyreticsappscombination antipyreticscomparative analysisfeverfever managementmHealthpatient-generated health data

Identifiers

PMID34037528
PMCPMC8190646
OpenAlexW3152843067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.